Loading...

Archive

    20 September 2018, Volume 15 Issue 9 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Study on Liver and Kidney Toxicity of 4 Components of Polygoni Multifori Radix on Mice after Intragastric Administration for 14 Days
    SONG Lei, WANG Qin, BI Yanan, SHI Hong, ZHANG Yue, ZHOU Kun
    2018, 15(9): 513-517. 
    Abstract ( 550 )   PDF (861KB) ( 290 )  
    Objective To study the liver and kidney toxicity of stilbeneglycoside, rhein, physcion and emodin and provide useful exploration for the hepatotoxicity study of Polygoni Multifori Radix. Methods 50 ICR mice were randomly divided into control group, stilbeneglycoside group, rhein group, physcion group and emodin group. Intragastric administration was performed once daily with the dosage of 100 mg·kg-1 and the control group was given a corresponding amount of normal saline for 14 days. After the last delivery, foods were forbidden but the water was provided for 12 hours. The body weights were weighed and serum, liver and kidney were obtained to calculate the hepatic index and renal coefficient. Serum biochemical indicators and mRNA level of liver bile acid transporter were detected. Results The body weight of rhein, physcion and emodin groups were lower than the control group (P <0.05) and the hepatic index of rhein increased significantly (P <0.05). TG, CRE, ALB and GLU of stilbeneglycoside group increased markedly (P <0.05 or P <0.01). Rhein, physcion and emodin of anthraquinones made BUN dramatically decreased (P <0.05 or P <0.01), while rhein and emodin could induce TG decreased (P <0.05 or P <0.01). The 4 drugs had significant effects on bile acid transporters such as MRP2 and BSEP (P <0.05 or P <0.01). Conclusion Stilbeneglycoside, rhein, physcion and emodin of Polygoni Multifori Radix could change the serum biochemical indicators of ICR mice with the dosage of 100 mg·kg-1 for 14 days and have obvious effects on different bile acid transporters.
    References | Related Articles | Metrics
    Treatment Effects and Mechanisms of Kangbingdu Oral Liquid Against the Infection of Influenza A (H1N1)
    MAO Xin, YAO Rongmei, GAO Yingjie, SUN Jing, BAO Lei, QU Tiange, SHI Yujing, GUO Shanshan, CUI Xiaolan
    2018, 15(9): 518-522. 
    Abstract ( 511 )   PDF (841KB) ( 321 )  
    Objective To observe the treatment effects and mechanisms of Kangbingdu oral liquid against influenza A (H1N1) virus infection. Methods ICR mice were infected by influenza A (H1N1) virus FM1 strain and PR8 strain. After treatment, the lung index, virus load and the level of MDA、TNF-α and IFN-γ in serum were measured; MDCK cells were infected by influenza A (H1N1) virus, after treatment, the activation of neuraminidase(NA) was measured. Results Compared with model group, Kangbingdu oral liquid significantly reduced the lung index of mice, significantly reduced the virus load, inhibited the level of TNF-α and increased the level of IFN-γ in vivo; Kangbingdu oral liquid significantly inhibited the activation of NA in vitro (P<0.05 or P<0.01). Conclusion Kangbingdu oral liquid has good therapeutic effects on viral pneumonia caused by influenza A (H1N1) virus through the inhibition of inflammatory response and virus copy.
    References | Related Articles | Metrics
    Effects of p38 Mitogen-activated Protein Kinase Inhibitor SB203580 on Proliferation and Growth Hormone Secretion of Rat Pituitary GH3 Cells
    HE Yue, GONG Lei, LI Chuzhong, WANG Hongyun, LI Dan, LIU Qian
    2018, 15(9): 523-525. 
    Abstract ( 296 )   PDF (1139KB) ( 175 )  
    Objective To observe the effects of p38 mitogen-activated protein kinase inhibitor SB203580 on proliferation and growth hormone secretion of rat pituitary GH3 cells and explore the p38 MAPK pathway as a potential therapy target for growth homone adenoma. Methods After treated with different concentrations of SB203580 for 24, 48, 72 h, the proliferation of rat pituitary GH3 cells was determined by MTT. The apoptosis levels were measured by Annexin V/PI. And the expression of growth hormone levels in the supernatant of GH3 cells treated with increasing concentrations of SB203580 for 72 h were measured by ELISA. Results SB203580 caused significant cytotoxicity in GH3 cells with a concentration- and time-dependent manner. Treatment with SB203580 induced GH3 cells apoptosis in a concentration-dependent manner (P <0.05). In addition, the level of growth hormone was significantly decreased in the supernatant of GH3 cells after exposure to SB203580 (P <0.05). Conclusion p38 mitogen-activated protein kinase inhibitor SB203580 may inhibit the proliferation and growth hormone secretion of rat pituitary GH3 cells.
    References | Related Articles | Metrics
    Study on Screening Natural Compounds Inhibiting Prolactinomas by Quantitative Imaging Flow Cytometry
    LI Dan, WANG Hongyun, LI Jianhua, LIU Qian, GAO Hua
    2018, 15(9): 526-529. 
    Abstract ( 338 )   PDF (940KB) ( 167 )  
    Objective To screen the natural compounds inhibiting prolactinomas MMQ cells with quantitative imaging flow cytometry, and observe the changes of prolactin levels. Methods Treated with 10 natural compounds to MMQ cells for 24 hours, cell morphology and apoptotic cells were determined by imaging flow cytometry. The medium prolactin level was measured by ELISA method. Cleaved Caspase 3 level was determined by Western blot method. Results Allylisothiocyante, tangeretin and xanthohumol screened from 10 natural compounds could effectively induce the MMQ cells apoptosis. After 24 hours treatment, the prolactin levels reduce to 48.3±13.2, 52.7±12.6 and 34.7±8.2 pg·mL-1, respectively, and 107.3±22.7 pg·mL-1 in control group. Western blot experiment showed the cleaved Caspase 3 level obviously increase after tangeretin and xanthohumol treatment (P<0.01). Conclusion Imaging flow cytometry has the advantage of combination of quantitative data analysis and fluorescent image, and allylisothiocyante, tangeretin and xanthohumol could be candidate drug for the prolactinomas treatment.
    References | Related Articles | Metrics
    Effects of ERK1/2 Pathway Inhibitor U0126 on Cell Proliferation of Growth Homone Adenoma GH3 Cells
    YANG Jingjng, FENG Jie,ZHAO Sida,XU Ning,GAO Hua
    2018, 15(9): 530-532. 
    Abstract ( 400 )   PDF (763KB) ( 115 )  
    Objective To study the effect of ERK1/2 pathway inhibitor, U0126, on the cell proliferation and apoptosis of rat GH3 cell line, so as to explore ERK1/2 pathway as a potential therapy target for growth homone adenoma. Methods GH3 cells were divided into U0126 groups and control group. The U0126 groups were given different concentrations of U0126 (10, 20 and 40 nM), and control group was given the equal volume of dimethyl sulfoxide (DMSO). The proliferation of GH3 cells was determined by MTS experiment, and the apoptosis levels were detected by flow cytometry. The p-ERK1/2 levels were measured by western blot. ResultCompared to control group, the cell viability of U0126 (10, 20 and 40 nM) were decreased by 14%, 15% and 19% after 24 h; 19%, 28% and 36% after 48 h; 24%, 37% and 52% after 72 h, respectively. After 72 h treatment, Annexin V positive cells in U0126 groups were 5.3%, 11.4% and 18.5%, and propidium iodide (PI) positive cells were 3.7%, 7.3% and 10.5%. The level of p-ERK protein in U0126 groups was decreased than that of control group, and 40 nM group was 41.7% of that in the control group. The difference was statistically significant (P <0.05). Conclusion The ERK1/2 pathway inhibitors, U0126, can induce apoptosis and inhibit cell proliferation in rat GH3 cells line.
    References | Related Articles | Metrics
    Effects of Decitabine on Pituitary-dependent Cushing's Disease in vitro
    ZHANG Li, ZHANG Hongxia
    2018, 15(9): 533-536. 
    Abstract ( 397 )   PDF (848KB) ( 117 )  
    Objective To observe the effects of decitabine on the proliferation, apoptosis and hormone secretion of adrenocorticotropic hormone (ACTH) pituitary adenoma AtT-20 cells. Methods The drug groups were given different concentrations of decitabine(1, 5, 10 μM), and control group was given equal volume of dimethyl sulfoxide (DMSO). The proliferation of AtT-20 cells was determined by MTS test after treated with different concentrations of decitabine for 24, 48, 72 h, and the apoptosis levels were measured by Annexin V/PI. Simultaneously, ACTH secretion ofAtT-20 cells by ELISA and the mRNA expression of apoptosis related genes such as Bax and Bcl-2 by Real-time PCR were detected. Results Compared with control group, decitabine could effectively inhibit the proliferation and ACTH secretion of AtT-20 cells in a concentration-dependent and time-dependent manner. After 72 h treatment, the apoptosis cells in decitabine groups were significantly increased. And the levels of Bax were increased and expressions of Bcl-2 mRNA were statistically decreased in decitabine groups than that of control group (P <0.05). Conclusion Decitabine can induce apoptosis of AtT-20 cells and inhibit cell proliferation and ACTH secretion. Decitabine might have a potential protective effect on pituitary-dependent Cushing's disease.
    References | Related Articles | Metrics
    Statistical Analysis of Clinical Characteristics of Tamoxifen-induced Fatty Liver in Patients with Breast Cancer
    ZHANG Zhen, MA Lei
    2018, 15(9): 537-540. 
    Abstract ( 405 )   PDF (754KB) ( 254 )  
    Objective To explore the clinical characteristics and regularity of tamoxifen-induced fatty liver in breast cancer patients. Methods To collect 227 cases of breast cancer patients treated with tamoxifen in our hospital from January 1st, 2011 to December 31st, 2017, of whom 78 cases had fatty liver before tamoxifen treatment, and the other 149 patients hadn't. The incidence and time to onset of fatty liver disease, liver function, body mass index (BMI), and the prognosis were analyzed for the patients without fatty liver before tamoxifen treatment. Results One hundred and thirty-one cases of new fatty liver were found after tamoxifen treatment in 149 patients, and the incidence was 87.92%. There was no statistically significant difference in the incidences between patients under 40 and those over 40(P=0.122), Among the 131 cases, 32.82% patients were diagnosed with fatty liver within 3 months, and 83.97% patients were diagnosed within 9 months. There was no statistically significant difference in the level of alanine aminotransferase (ALT) after tamoxifen treatment between the patients with newly diagnosed fatty liver and the patients without fatty liver. Among patients with newly diagnosed fatty liver, 9.16% (12/131) of the tamoxifen-induced fatty liver patients improved themselves during medication, 26.53% (13/49) disappeared after the withdrawal of tamoxifen. Statistical Results showed that the incidence of fatty liver in patients after taking tamoxifen was not related to BMI. Conclusion The incidence of fatty liver in breast cancer patients treated with tamoxifen was relatively high in our hospital, and the occurrence of fatty liver had no significant relationship with the patient's age, ALT, and BMI.
    References | Related Articles | Metrics
    Cognitive Investigation on Drug Abuse and Drug Abuse Monitoring among Linyi Medical Staff
    CHEN Yafei, HUANG Yuan, DONG Fang, QIU Jianmin
    2018, 15(9): 541-544. 
    Abstract ( 374 )   PDF (746KB) ( 129 )  
    Objective To master the cognitive status of medical staff on drug abuse and drug abuse monitoring and provide evidence for drug abuse monitoring in medical institutions. Methods 51 medical institutions were selected in Linyi by typical sampling, and a cross-sectional survey using self-filling questionnaire was carried out on medical staff of high-risk departments to contact with drug abuse population by convenience sampling. Results 141 medical staff were investigated effectively, 85.82% of respondents reported understanding drug abuse, and 79.43% of respondents reported they knew the diagnostic criteria of drug abuse, and 74.47% of respondents reported they knew drug abuse monitoring. Less than 60% of the medical staff considered compound codeine phosphate oral solution, compound diphenoxylate tablets, compound liquorice tablets generating drug dependence. Less than 50% of medical staff thought compound aminopyrine phenacetin tablets, dextromethorphan producing drug dependence. Difference in cognitive scores between different levels of medical institutions was statistically significant (P <0.05). Conclusion Medical staff in our city need to improve their cognition of drug abuse and drug abuse monitoring.
    References | Related Articles | Metrics
    Preliminary Discussion on the Risk Management of QT-prolonging Drugs Use and Its Implication
    DING Faming, ZHANG Xinli, WANG Qiong, YIN Maoshan
    2018, 15(9): 545-549. 
    Abstract ( 425 )   PDF (780KB) ( 289 )  
    Objective To provide reference for the post-marketing risk management and safe use of QT-prolonging drugs in China by introducting CredibleMeds website, an important tool used by the United States to determine the clinical use of QT-prolonging drugs. Methods Literature study was used. Based on the overview of the diLQTS mechanism and factors contributing to risk of TdP, the risk categorization and risk management strategies for QT prolonging drugs were described according to the CredibleMeds website. Results With optimizing the allocation of resources, US FDA advocated the establishment of an independent QT-prolonging drugs risk management platform by an independent education and research institution and improved the utilization of safety information and drug risk management efficiency. Conclusion We should learn from the experience of drug risk management in the United States to improve the risk management capabilities of QT-prolonging drugs.
    References | Related Articles | Metrics
    Analysis on Characteristics of Antibacterial Use in Inpatients with Chronic Kidney Disease
    CHEN Tianao, LIU Xiao, LIANG Yan
    2018, 15(9): 550-554. 
    Abstract ( 408 )   PDF (739KB) ( 176 )  
    Objective To investigate the use of antibacterials in patients with chronic kidney disease(CKD) and evaluate the drug safety for providing some clinical reference. Methods Inpatients with CKD over a 10-month period from January to October, 2014 in our hospital were analyzed retrospectively. Results In the 1 793 cases of hospitalized patients with CKD, the incidence of infection was 20.86%, mainly respiratory and urinary tract infections. 495 cases were treated with antibacterials, 345 cases for treating and 150 cases for preventing. In cases for treating, pathogenic bacteria were detected in 69.52% of the patients. Quinolones and cephalosporins were the most commonly used antibacterials. There were 66 cases with drug combinations, 22 cases with adverse drug reactions, and the adverse reactions of digestive system were the most common. Conclusion Inpatients with CKD are basically safe to use antibiotics. The dosage regimen should be adjusted by renal condition in the clinic.
    References | Related Articles | Metrics
    Clinical Application and Potential Risk of CAR-T
    XU Xianxing, YANG Jingwen
    2018, 15(9): 555-559. 
    Abstract ( 357 )   PDF (687KB) ( 247 )  
    Objective To introduce clinical application of chimeric antigen receptor T-cell therapy (CAR-T) and to explore the influencing factors of efficacy and potential risks. Methods Analyze information that affects the efficacy and safety of CAR-T therapy by retrieving literature and related databases at home and aboard. Results CAR-T provides a new treatment for cancer patients, but there are still many problems to be solved in terms of efficacy and safety. Conclusion CAR-T has shown great potential and will bring tumor immunotherapy to a new stage though many challenges ahead.
    References | Related Articles | Metrics
    Progress of Hypomethylating Agents in Treatment of Myelodysplastic Syndrome
    CHANG Bingqing, SUN Wanling
    2018, 15(9): 560-563. 
    Abstract ( 309 )   PDF (594KB) ( 542 )  
    Myelodysplastic syndrome (MDS) is a group of heterogeneous myeloid clonal diseases originated from hematopoietic stem cells and has a high risk to transform into acute myeloid leukemia. The natural course and prognosis of MDS patients are highly heterogeneous, and individualized treatment plans must be developed according to the stratification of patients' prognosis. Currently, hypomethylating agents are one of the main treatments for high-risk MDS patients. This paper summarizes the research progress of representative hypomethylating agents in recent years, and hopes to provide references for the clinical application and research of these drugs.
    References | Related Articles | Metrics
    Review of New Drugs with QIDP Certification Approved by FDA
    NIU Yaping, LIANG Beibei, SUN Pai, WANG Rui, JIA Jinsheng
    2018, 15(9): 564-571. 
    Abstract ( 399 )   PDF (579KB) ( 344 )  
    ObjectiveTo overview the 8 new antibacterials with QIDP certification approved by the FDA. Methods The relevant 75 papers about 8 FDA approved QIDP antibacterial drugs were summarized and analyzed. Results At present, 8 antibacterial drugs with QIDP qualification have been marketed and are suitable for the treatment of serious infections caused by drug-resistant pathogens. They have the characteristics of broad antibacterial spectrum, strong antibacterial activity, and good tolerance. Conclusion Facing with the challenge of global drug resistance, the 8 antibacterial drugs with QIDP certification approved by the FDA are worthy of more research.
    References | Related Articles | Metrics
    One Case of Muscular Calf Vein Thrombosis Induced by Off -label Use of Haemocoagulase Agkistrodon for Injection
    JIANG Yongxian, LI Gen, WANG Han, LI Li
    2018, 15(9): 572-573. 
    Abstract ( 547 )   PDF (516KB) ( 353 )  
    References | Related Articles | Metrics
    One Case of Rhabdomyolysis Induced by Rosuvastatin Calcium Combined with Colchicine Tablets
    CHEN Huanlei, ZHAO Xiaoyan, DONG Yang, WANG Zhenhua
    2018, 15(9): 574-574. 
    Abstract ( 626 )   PDF (506KB) ( 249 )  
    References | Related Articles | Metrics
    One Case of Muscle Ache Induced by Pantoprazole Sodium for Injection and Rabeprazole Enteric-coated Capsule
    TAN Zhaodan, GU Weiying, LUO Lan, SHI Kourong, CHEN Weicheng
    2018, 15(9): 575-576. 
    Abstract ( 402 )   PDF (525KB) ( 198 )  
    References | Related Articles | Metrics